Duloxetine Compared With Placebo in Patients With Generalized Anxiety Disorder

Duloxetine Hydrochloride 60 mg or 120 mg Once Daily Compared With Placebo in Patients With Generalized Anxiety Disorder.

This is a clinical trial assessing duloxetine compared with placebo in patients who have generalized anxiety disorder.

Inclusion Criteria:

• Male and female outpatients at least 18 years of age

Exclusion Criteria:

• Have previously completed or withdrawn from this study or any other study investigating duloxetine or have previously been treated with duloxetine
• Patient diagnosed with major depressive disorder within the past 6 months
• Patient diagnosed with panic disorder, post-traumatic stress disorder, or an eating disorder within the past year
• History of alcohol or any psychoactive substance abuse or dependence within the past 6 months